{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T02:29:45Z","timestamp":1788834585286,"version":"build-2803163510"},"reference-count":193,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2025MD784174"],"award-info":[{"award-number":["2025MD784174"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010009","name":"Heilongjiang Provincial Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["LBH-Z25086"],"award-info":[{"award-number":["LBH-Z25086"]}],"id":[{"id":"10.13039\/501100010009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012548","name":"Heilongjiang Postdoctoral Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012548","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U24A20452"],"award-info":[{"award-number":["U24A20452"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology &amp; Therapeutics"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.pharmthera.2026.109092","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:35:07Z","timestamp":1784853307000},"page":"109092","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["AI-assisted design of next-generation antibiotics against multidrug-resistant Staphylococcus aureus"],"prefix":"10.1016","volume":"286","author":[{"given":"Youle","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinyuan","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junchen","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yadan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8016","key":"10.1016\/j.pharmthera.2026.109092_bb0005","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","article-title":"Accurate structure prediction of biomolecular interactions with AlphaFold 3","volume":"630","author":"Abramson","year":"2024","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109092_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2026.104602","article-title":"Transformers in drug discovery: Fine-tuning ChemBERTa for high-accuracy prediction of solubility, toxicity and binding affinity","volume":"31","author":"Alagarsamy","year":"2026","journal-title":"Drug Discovery Today"},{"issue":"D1","key":"10.1016\/j.pharmthera.2026.109092_bb0015","doi-asserted-by":"crossref","first-page":"D690","DOI":"10.1093\/nar\/gkac920","article-title":"CARD 2023: Expanded curation, support for machine learning, and resistome prediction at the comprehensive antibiotic resistance database","volume":"51","author":"Alcock","year":"2023","journal-title":"Nucleic Acids Research"},{"issue":"D1","key":"10.1016\/j.pharmthera.2026.109092_bb0020","first-page":"D517","article-title":"CARD 2020: Antibiotic resistome surveillance with the comprehensive antibiotic resistance database","volume":"48","author":"Alcock","year":"2020","journal-title":"Nucleic Acids Research"},{"issue":"7943","key":"10.1016\/j.pharmthera.2026.109092_bb0025","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/s41586-022-05583-3","article-title":"Structural basis of broad-spectrum \u03b2-lactam resistance in Staphylococcus aureus","volume":"613","author":"Alexander","year":"2023","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109092_bb0030","doi-asserted-by":"crossref","DOI":"10.15190\/d.2019.15","article-title":"FDA approved antibacterial drugs: 2018-2019","volume":"7","author":"Andrei","year":"2019","journal-title":"Discoveries"},{"issue":"16","key":"10.1016\/j.pharmthera.2026.109092_bb0035","doi-asserted-by":"crossref","first-page":"8736","DOI":"10.1021\/jacs.2c13467","article-title":"Generative models as an emerging paradigm in the chemical sciences","volume":"145","author":"Anstine","year":"2023","journal-title":"Journal of the American Chemical Society"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109092_bb0040","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0924-8579(00)00192-8","article-title":"The fluoroquinolone antibacterials: Past, present and future perspectives","volume":"16","author":"Appelbaum","year":"2000","journal-title":"International Journal of Antimicrobial Agents"},{"issue":"6557","key":"10.1016\/j.pharmthera.2026.109092_bb0045","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1126\/science.abj8754","article-title":"Accurate prediction of protein structures and interactions using a three-track neural network","volume":"373","author":"Baek","year":"2021","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109092_bb0050","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1007\/s40121-025-01146-x","article-title":"Meropenem\u2013vaborbactam for treatment of carbapenem-resistant enterobacterales: A narrative review of clinical practice evidence","volume":"14","author":"Bassetti","year":"2025","journal-title":"Infectious Diseases and Therapy"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109092_bb0055","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.cmi.2024.06.006","article-title":"Community methicillin-resistant Staphylococcus aureus outbreaks in areas of low prevalence","volume":"31","author":"Bellis","year":"2025","journal-title":"Clinical Microbiology and Infection"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109092_bb0060","doi-asserted-by":"crossref","DOI":"10.1093\/femsre\/fuae002","article-title":"The role of human extracellular matrix proteins in defining Staphylococcus aureus biofilm infections","volume":"48","author":"Bhattacharya","year":"2024","journal-title":"FEMS Microbiology Reviews"},{"issue":"22","key":"10.1016\/j.pharmthera.2026.109092_bb0065","doi-asserted-by":"crossref","first-page":"20639","DOI":"10.1021\/acs.jmedchem.4c02196","article-title":"Single amine or guanidine modification on Norvancomycin and vancomycin to overcome multidrug-resistance through augmented lipid II binding and increased membrane activity","volume":"67","author":"Bian","year":"2024","journal-title":"Journal of Medicinal Chemistry"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109092_bb0070","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/s41587-021-01179-w","article-title":"Using deep learning to annotate the protein universe","volume":"40","author":"Bileschi","year":"2022","journal-title":"Nature Biotechnology"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109092_bb0075","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1021\/acsinfecdis.7b00258","article-title":"Developments in Glycopeptide antibiotics","volume":"4","author":"Blaskovich","year":"2018","journal-title":"ACS Infectious Diseases"},{"issue":"7","key":"10.1016\/j.pharmthera.2026.109092_bb0080","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1021\/acsinfecdis.5b00044","article-title":"Helping chemists discover new antibiotics","volume":"1","author":"Blaskovich","year":"2015","journal-title":"ACS Infectious Diseases"},{"issue":"D1","key":"10.1016\/j.pharmthera.2026.109092_bb0085","doi-asserted-by":"crossref","first-page":"D744","DOI":"10.1093\/nar\/gkac1047","article-title":"MEGARes and AMR++, v3.0: An updated comprehensive database of antimicrobial resistance determinants and an improved software pipeline for classification using high-throughput sequencing","volume":"51","author":"Bonin","year":"2023","journal-title":"Nucleic Acids Research"},{"issue":"10","key":"10.1016\/j.pharmthera.2026.109092_bb0090","doi-asserted-by":"crossref","first-page":"S167","DOI":"10.1016\/j.spinee.2017.07.247","article-title":"Comparative description of in vitro and in vivo MRSA biofilms on titanium surfaces: Why animal models still matter","volume":"17","author":"Bouloussa","year":"2017","journal-title":"The Spine Journal"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109092_bb0095","doi-asserted-by":"crossref","DOI":"10.1080\/21505594.2024.2359483","article-title":"The pathogenicity and virulence of the opportunistic pathogen Staphylococcus epidermidis","volume":"15","author":"Burke","year":"2024","journal-title":"Virulence"},{"issue":"16","key":"10.1016\/j.pharmthera.2026.109092_bb0100","doi-asserted-by":"crossref","first-page":"8683","DOI":"10.1021\/acs.jmedchem.9b02147","article-title":"Transfer learning for drug discovery","volume":"63","author":"Cai","year":"2020","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2026.109092_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2025.101295","article-title":"Staphylococcus aureus manipulates osteocytes to cause persistent chronic osteomyelitis and antibiotic resistance via pyroptosis pathway suppression","volume":"84","author":"Cai","year":"2026","journal-title":"Drug Resistance Updates"},{"issue":"16","key":"10.1016\/j.pharmthera.2026.109092_bb0110","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1093\/bioinformatics\/btx200","article-title":"TIN-X: Target importance and novelty explorer","volume":"33","author":"Cannon","year":"2017","journal-title":"Bioinformatics"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109092_bb0115","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/s41592-024-02516-y","article-title":"SurfDock is a surface-informed diffusion generative model for reliable and accurate protein\u2013ligand complex prediction","volume":"22","author":"Cao","year":"2025","journal-title":"Nature Methods"},{"issue":"11","key":"10.1016\/j.pharmthera.2026.109092_bb0120","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1038\/s41589-023-01448-6","article-title":"Antibiotic identified by AI","volume":"19","author":"Cesaro","year":"2023","journal-title":"Nature Chemical Biology"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109092_bb0125","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ijantimicag.2007.11.014","article-title":"Macrolide\u2013lincosamide\u2013streptogramin B resistance phenotypes in clinical staphylococcal isolates","volume":"31","author":"Cetin","year":"2008","journal-title":"International Journal of Antimicrobial Agents"},{"issue":"7","key":"10.1016\/j.pharmthera.2026.109092_bb0130","doi-asserted-by":"crossref","first-page":"3976","DOI":"10.1128\/AAC.00589-16","article-title":"Daptomycin\u2013\u03b2-lactam combinations in a rabbit model of daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus endocarditis","volume":"60","author":"Chambers","year":"2016","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109092_bb0135","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1021\/acs.jcim.5c02846","article-title":"Fine-tuning DiffDock-L for allosteric kinase docking","volume":"66","author":"Chen","year":"2026","journal-title":"Journal of Chemical Information and Modeling"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109092_bb0140","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/s41684-018-0217-2","article-title":"Nonhuman primate species as models of human bacterial sepsis","volume":"48","author":"Chen","year":"2019","journal-title":"Lab Animal"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109092_bb0145","doi-asserted-by":"crossref","DOI":"10.1093\/bioinformatics\/btad059","article-title":"Potent antibiotic design via guided search from antibacterial activity evaluations","volume":"39","author":"Chen","year":"2023","journal-title":"Bioinformatics"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109092_bb0150","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1186\/s12967-023-04233-0","article-title":"Uncovering the mechanism of resveratrol in the treatment of diabetic kidney disease based on network pharmacology, molecular docking, and experimental validation","volume":"21","author":"Chen","year":"2023","journal-title":"Journal of Translational Medicine"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109092_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2025.107499","article-title":"Profiling of omadacycline resistance in clinical MRSA: A nationwide genomic survey and in vitro evolutionary analysis","volume":"66","author":"Chen","year":"2025","journal-title":"International Journal of Antimicrobial Agents"},{"issue":"10","key":"10.1016\/j.pharmthera.2026.109092_bb0160","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1021\/acs.jcim.3c00045","article-title":"Fingerprint-enhanced graph attention network (FinGAT) model for antibiotic discovery","volume":"63","author":"Choo","year":"2023","journal-title":"Journal of Chemical Information and Modeling"},{"key":"10.1016\/j.pharmthera.2026.109092_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.mib.2026.102724","article-title":"Harnessing artificial intelligence for antimicrobial discovery and optimization","volume":"91","author":"Clements","year":"2026","journal-title":"Current Opinion in Microbiology"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109092_bb0170","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s42254-025-00896-4","article-title":"Cryogenic electron microscopy and tomography for beam-sensitive materials","volume":"8","author":"Cui","year":"2026","journal-title":"Nature Reviews Physics"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109092_bb0175","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1080\/21505594.2019.1621649","article-title":"Galleria mellonella as a consolidated in vivo model hosts: New developments in antibacterial strategies and novel drug testing","volume":"10","author":"Cutuli","year":"2019","journal-title":"Virulence"},{"key":"10.1016\/j.pharmthera.2026.109092_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114213","article-title":"Alternative approaches utilizing click chemistry to develop next-generation analogs of solithromycin","volume":"233","author":"Daher","year":"2022","journal-title":"European Journal of Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2026.109092_bb0185","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.93242.4","article-title":"An antimicrobial drug recommender system using MALDI-TOF MS and dual-branch neural networks","volume":"13","author":"De Waele","year":"2024","journal-title":"Elife"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109092_bb0190","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s40265-019-1053-4","article-title":"Sarecycline: First global approval","volume":"79","author":"Deeks","year":"2019","journal-title":"Drugs"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109092_bb0195","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s42256-024-00843-5","article-title":"Machine learning-aided generative molecular design","volume":"6","author":"Du","year":"2024","journal-title":"Nature Machine Intelligence"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109092_bb0200","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s40265-019-1054-3","article-title":"Plazomicin: A novel aminoglycoside for the treatment of resistant gram-negative bacterial infections","volume":"79","author":"Eljaaly","year":"2019","journal-title":"Drugs"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.109092_bb0205","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.201800141","article-title":"Recent updates of fluoroquinolones as antibacterial agents","volume":"351","author":"Ezelarab","year":"2018","journal-title":"Archiv der Pharmazie"},{"issue":"10","key":"10.1016\/j.pharmthera.2026.109092_bb0210","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1038\/s42256-023-00721-6","article-title":"A method for multiple-sequence-alignment-free protein structure prediction using a protein language model","volume":"5","author":"Fang","year":"2023","journal-title":"Nature Machine Intelligence"},{"key":"10.1016\/j.pharmthera.2026.109092_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2023.108550","article-title":"Multitarget antibacterial drugs: An effective strategy to combat bacterial resistance","volume":"252","author":"Feng","year":"2023","journal-title":"Pharmacology & Therapeutics"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109092_bb0220","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1021\/acs.jcim.4c00087","article-title":"Machine learning-based virtual screening of antibacterial agents against methicillin-susceptible and resistant Staphylococcus aureus","volume":"64","author":"Fernandes","year":"2024","journal-title":"Journal of Chemical Information and Modeling"},{"issue":"12","key":"10.1016\/j.pharmthera.2026.109092_bb0225","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/s41579-023-00933-y","article-title":"Antibiotic perturbations to the gut microbiome","volume":"21","author":"Fishbein","year":"2023","journal-title":"Nature Reviews Microbiology"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109092_bb0230","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.tim.2018.06.005","article-title":"Can \u03b2-lactam antibiotics be resurrected to combat MRSA?","volume":"27","author":"Foster","year":"2019","journal-title":"Trends in Microbiology"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109092_bb0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/17460441.2025.2601876","article-title":"Using biophysical techniques to enhance early-stage drug discovery: The impact and challenges","volume":"21","author":"Fuchs","year":"2026","journal-title":"Expert Opinion on Drug Discovery"},{"key":"10.1016\/j.pharmthera.2026.109092_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2023.101012","article-title":"Antibiotic failure: Beyond antimicrobial resistance","volume":"71","author":"de la Fuente-Nunez","year":"2023","journal-title":"Drug Resistance Updates"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109092_bb0245","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1021\/acs.jcim.4c02347","article-title":"Predicting antimicrobial class specificity of small molecules using machine learning","volume":"65","author":"Gadiya","year":"2025","journal-title":"Journal of Chemical Information and Modeling"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109092_bb0250","doi-asserted-by":"crossref","DOI":"10.1128\/mmbr.00037-22","article-title":"Antimicrobial peptides and small molecules targeting the cell membrane of Staphylococcus aureus","volume":"87","author":"Ganesan","year":"2023","journal-title":"Microbiology and Molecular Biology Reviews"},{"issue":"41","key":"10.1016\/j.pharmthera.2026.109092_bb0255","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2415665122","article-title":"Generative AI for navigating synthesizable chemical space","volume":"122","author":"Gao","year":"2025","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"10.1016\/j.pharmthera.2026.109092_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.113056","article-title":"Potentials of nanotechnology in treatment of methicillin-resistant Staphylococcus aureus","volume":"213","author":"Gao","year":"2021","journal-title":"European Journal of Medicinal Chemistry"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109092_bb0265","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/s41596-021-00659-2","article-title":"Artificial intelligence\u2013enabled virtual screening of ultra-large chemical libraries with deep docking","volume":"17","author":"Gentile","year":"2022","journal-title":"Nature Protocols"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109092_bb0270","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.cmi.2021.08.007","article-title":"Pretomanid for tuberculosis: A systematic review","volume":"28","author":"Gils","year":"2022","journal-title":"Clinical Microbiology and Infection"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109092_bb0275","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1038\/s41467-021-23303-9","article-title":"Structure-based protein function prediction using graph convolutional networks","volume":"12","author":"Gligorijevi\u0107","year":"2021","journal-title":"Nature Communications"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109092_bb0280","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1093\/jac\/dkp434","article-title":"In vitro pharmacodynamic models to determine the effect of antibacterial drugs","volume":"65","author":"Gloede","year":"2010","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109092_bb0285","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s42004-025-01801-x","article-title":"Binding mode of Isoxazolyl Penicillins to a class-a \u03b2-lactamase at ambient conditions","volume":"8","author":"Gore","year":"2025","journal-title":"Communications Chemistry"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109092_bb0290","doi-asserted-by":"crossref","first-page":"185","DOI":"10.4161\/viru.22507","article-title":"New antibiotic agents in the pipeline and how they can help overcome microbial resistance","volume":"4","author":"Gould","year":"2013","journal-title":"Virulence"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109092_bb0295","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1021\/acs.jcim.5c02332","article-title":"Chemprop v2: An efficient, modular machine learning package for chemical property prediction","volume":"66","author":"Graff","year":"2025","journal-title":"Journal of Chemical Information and Modeling"},{"issue":"16","key":"10.1016\/j.pharmthera.2026.109092_bb0300","doi-asserted-by":"crossref","first-page":"6943","DOI":"10.1039\/D5SC01476J","article-title":"Directly optimizing for synthesizability in generative molecular design using retrosynthesis models","volume":"16","author":"Guo","year":"2025","journal-title":"Chemical Science"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109092_bb0305","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/s43588-026-00959-1","article-title":"TANGO: Direct optimization of constrained synthesizability for generative molecular design","volume":"6","author":"Guo","year":"2026","journal-title":"Nature Computational Science"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109092_bb0310","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/s41587-023-01917-2","article-title":"Protein remote homology detection and structural alignment using deep learning","volume":"42","author":"Hamamsy","year":"2024","journal-title":"Nature Biotechnology"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109092_bb0315","first-page":"3","article-title":"Challenges and opportunities for validation of AI-based new approach methods","volume":"42","author":"Hartung","year":"2025","journal-title":"Altex"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109092_bb0320","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s40265-021-01471-8","article-title":"Imipenem\/Cilastatin\/Relebactam: A review in gram-negative bacterial infections: Y.-a. Heo","volume":"81","author":"Heo","year":"2021","journal-title":"Drugs"},{"key":"10.1016\/j.pharmthera.2026.109092_bb0325","first-page":"1","article-title":"Enhancing link prediction in biomedical knowledge graphs with BioPathNet","author":"Hu","year":"2026","journal-title":"Nature Biomedical Engineering"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109092_bb0330","doi-asserted-by":"crossref","first-page":"7928","DOI":"10.1038\/s41467-025-63245-0","article-title":"Target-aware 3D molecular generation based on guided equivariant diffusion","volume":"16","author":"Hu","year":"2025","journal-title":"Nature Communications"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109092_bb0335","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13321-025-01006-3","article-title":"Activity cliff-aware reinforcement learning for de novo drug design","volume":"17","author":"Hu","year":"2025","journal-title":"Journal of Cheminformatics"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109092_bb0340","article-title":"Machine learning for antimicrobial resistance prediction: Current practice, limitations, and clinical perspective","volume":"35","author":"Jee","year":"2022","journal-title":"Clinical Microbiology Reviews"},{"issue":"31","key":"10.1016\/j.pharmthera.2026.109092_bb0345","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adg5995","article-title":"Killing of Staphylococcus aureus persisters by a multitarget natural product chrysomycin a","volume":"9","author":"Jia","year":"2023","journal-title":"Science Advances"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.109092_bb0350","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.00556-25","article-title":"Machine learning-selected minimal features drive high-accuracy rule-based antibiotic susceptibility predictions for Staphylococcus aureus via metagenomic sequencing","volume":"13","author":"Jia","year":"2025","journal-title":"Microbiology Spectrum"},{"issue":"6781","key":"10.1016\/j.pharmthera.2026.109092_bb0355","doi-asserted-by":"crossref","DOI":"10.1126\/science.ads9530","article-title":"Deep contrastive learning enables genome-wide virtual screening","volume":"391","author":"Jia","year":"2026","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109092_bb0360","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/s42256-024-00808-8","article-title":"PocketFlow is a data-and-knowledge-driven structure-based molecular generative model","volume":"6","author":"Jiang","year":"2024","journal-title":"Nature Machine Intelligence"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.109092_bb0365","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1007\/s40262-020-00892-0","article-title":"Preclinical pharmacokinetic\/Pharmacodynamic studies and clinical trials in the drug development process of EMA-approved antibacterial agents: A review","volume":"59","author":"Jorda","year":"2020","journal-title":"Clinical Pharmacokinetics"},{"issue":"7873","key":"10.1016\/j.pharmthera.2026.109092_bb0370","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"issue":"29","key":"10.1016\/j.pharmthera.2026.109092_bb0375","doi-asserted-by":"crossref","first-page":"13196","DOI":"10.1039\/D5SC01778E","article-title":"Guided multi-objective generative AI to enhance structure-based drug design","volume":"16","author":"Kadan","year":"2025","journal-title":"Chemical Science"},{"issue":"10","key":"10.1016\/j.pharmthera.2026.109092_bb0380","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.1021\/acs.jcim.3c01619","article-title":"PandaOmics: An AI-driven platform for therapeutic target and biomarker discovery","volume":"64","author":"Kamya","year":"2024","journal-title":"Journal of Chemical Information and Modeling"},{"key":"10.1016\/j.pharmthera.2026.109092_bb0385","doi-asserted-by":"crossref","DOI":"10.1016\/j.copbio.2024.103175","article-title":"Generative artificial intelligence for small molecule drug design","volume":"89","author":"Kanakala","year":"2024","journal-title":"Current Opinion in Biotechnology"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109092_bb0390","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2023.106971","article-title":"Genetic alterations in methicillin-susceptible Staphylococcus aureus associated with high vancomycin minimum inhibitory concentration","volume":"62","author":"Kang","year":"2023","journal-title":"International Journal of Antimicrobial Agents"},{"issue":"12","key":"10.1016\/j.pharmthera.2026.109092_bb0395","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1080\/17460441.2020.1798926","article-title":"Open access in silico tools to predict the ADMET profiling of drug candidates","volume":"15","author":"Kar","year":"2020","journal-title":"Expert Opinion on Drug Discovery"},{"issue":"13","key":"10.1016\/j.pharmthera.2026.109092_bb0400","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1007\/s40265-023-01920-6","article-title":"Sulbactam\/Durlobactam: First approval: SJ Keam","volume":"83","author":"Keam","year":"2023","journal-title":"Drugs"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109092_bb0405","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s40265-024-02035-2","article-title":"Cefepime\/enmetazobactam: First approval","volume":"84","author":"Keam","year":"2024","journal-title":"Drugs"},{"issue":"11","key":"10.1016\/j.pharmthera.2026.109092_bb0410","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1007\/s40265-025-02214-9","article-title":"Gepotidacin: First approval: SJ Keam","volume":"85","author":"Keam","year":"2025","journal-title":"Drugs"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109092_bb0415","doi-asserted-by":"crossref","first-page":"731","DOI":"10.2165\/11207380-000000000-00000","article-title":"Sitafloxacin","volume":"71","author":"Keating","year":"2011","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109092_bb0420","doi-asserted-by":"crossref","DOI":"10.1002\/inmd.70064","article-title":"TargetGen-RNN model discovers novel antibiotic compound targeting drug-resistant Staphylococcus aureus","volume":"4","author":"Khan","year":"2026","journal-title":"Interdisciplinary Medicine"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.109092_bb0425","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2211823120","article-title":"Improved global protein homolog detection with major gains in function identification","volume":"120","author":"Kilinc","year":"2023","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"11","key":"10.1016\/j.pharmthera.2026.109092_bb0430","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.00645-25","article-title":"Correlation of QRDR mutations and MIC levels in fluoroquinolone-resistant Staphylococcus aureus clinical isolates","volume":"13","author":"Kim","year":"2025","journal-title":"Microbiology Spectrum"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109092_bb0435","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3390\/ph18020196","article-title":"In silico approach for antibacterial discovery: PTML modeling of virtual multi-strain inhibitors against Staphylococcus aureus","volume":"18","author":"Kleandrova","year":"2025","journal-title":"Pharmaceuticals"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.109092_bb0440","doi-asserted-by":"crossref","first-page":"707","DOI":"10.4161\/viru.26572","article-title":"Seasonal H3N2 influenza a virus fails to enhance Staphylococcus aureus co-infection in a non-human primate respiratory tract infection model","volume":"4","author":"Kobayashi","year":"2013","journal-title":"Virulence"},{"issue":"10","key":"10.1016\/j.pharmthera.2026.109092_bb0445","doi-asserted-by":"crossref","DOI":"10.1016\/j.patter.2022.100588","article-title":"SELFIES and the future of molecular string representations","volume":"3","author":"Krenn","year":"2022","journal-title":"Patterns"},{"issue":"21","key":"10.1016\/j.pharmthera.2026.109092_bb0450","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2025.07.033","article-title":"A generative deep learning approach to <em>de novo<\/em> antibiotic design","volume":"188","author":"Krishnan","year":"2025","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2026.109092_bb0455","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmgm.2022.108361","article-title":"De novo design of anti-tuberculosis agents using a structure-based deep learning method","volume":"118","author":"Krishnan","year":"2023","journal-title":"Journal of Molecular Graphics and Modelling"},{"issue":"10","key":"10.1016\/j.pharmthera.2026.109092_bb0460","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1039\/D2NP00084A","article-title":"Natural products acting against S. Aureus through membrane and cell wall disruption","volume":"40","author":"Kumar","year":"2023","journal-title":"Natural Product Reports"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109092_bb0465","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s13321-025-01028-x","article-title":"Equivariant diffusion for structure-based de novo ligand generation with latent-conditioning","volume":"17","author":"Le","year":"2025","journal-title":"Journal of Cheminformatics"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109092_bb0470","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbaf454","article-title":"Beyond rigid docking: Deep learning approaches for fully flexible protein\u2013ligand interactions","volume":"26","author":"Lee","year":"2025","journal-title":"Briefings in Bioinformatics"},{"issue":"17","key":"10.1016\/j.pharmthera.2026.109092_bb0475","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1007\/s40265-019-01219-5","article-title":"Leave it to lefamulin: A pleuromutilin treatment option in community-acquired bacterial pneumonia: YR Lee, KL Jacobs","volume":"79","author":"Lee","year":"2019","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109092_bb0480","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.cell.2020.02.056","article-title":"The science of antibiotic discovery","volume":"181","author":"Lewis","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2026.109092_bb0485","first-page":"21","article-title":"FlowDock: A unified flow-based framework for flexible protein-ligand docking and binding affinity prediction","volume":"4","author":"Li","year":"2026","journal-title":"Acta Pharmaceutica Sinica B"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109092_bb0490","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1186\/s12866-025-04331-7","article-title":"In vitro activity of Eravacycline against carbapenem-resistant gram-negative bacilli and associated risk factors for non-susceptible infections from a tertiary hospital in Fujian, China from 2021 to 2024","volume":"25","author":"Li","year":"2025","journal-title":"BMC Microbiology"},{"key":"10.1016\/j.pharmthera.2026.109092_bb0495","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2024.1482186","article-title":"Artificial intelligence in predicting pathogenic microorganisms\u2019 antimicrobial resistance: Challenges, progress, and prospects","volume":"14","author":"Li","year":"2024","journal-title":"Frontiers in Cellular and Infection Microbiology"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109092_bb0500","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s40168-021-01002-3","article-title":"HMD-ARG: Hierarchical multi-task deep learning for annotating antibiotic resistance genes","volume":"9","author":"Li","year":"2021","journal-title":"Microbiome"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109092_bb0505","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1039\/C9SC04503A","article-title":"Scaffold-based molecular design with a graph generative model","volume":"11","author":"Lim","year":"2020","journal-title":"Chemical Science"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109092_bb0510","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3390\/antibiotics10030285","article-title":"Antimicrobial effects of minocycline, Tigecycline, ciprofloxacin, and levofloxacin against Elizabethkingia anophelis using in vitro time-kill assays and in vivo zebrafish animal models","volume":"10","author":"Lin","year":"2021","journal-title":"Antibiotics"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109092_bb0515","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40779-024-00510-1","article-title":"Antimicrobial resistance crisis: Could artificial intelligence be the solution?","volume":"11","author":"Liu","year":"2024","journal-title":"Military Medical Research"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109092_bb0520","doi-asserted-by":"crossref","DOI":"10.1080\/21505594.2025.2451163","article-title":"Staphylococcus aureus nt5 gene mutation through CRISPR RNA-guided base editing weakens bacterial virulence and immune evasion","volume":"16","author":"Liu","year":"2025","journal-title":"Virulence"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109092_bb0525","doi-asserted-by":"crossref","first-page":"e285","DOI":"10.1093\/cid\/ciaf280","article-title":"Pivmecillinam for treatment of uncomplicated urinary tract infection: New efficacy analysis","volume":"81","author":"Lodise","year":"2025","journal-title":"Clinical Infectious Diseases"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109092_bb0530","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/s41467-024-45461-2","article-title":"DynamicBind: Predicting ligand-specific protein-ligand complex structure with a deep equivariant generative model","volume":"15","author":"Lu","year":"2024","journal-title":"Nature Communications"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109092_bb0535","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbac409","article-title":"BioGPT: Generative pre-trained transformer for biomedical text generation and mining","volume":"23","author":"Luo","year":"2022","journal-title":"Briefings in Bioinformatics"},{"key":"10.1016\/j.pharmthera.2026.109092_bb0540","doi-asserted-by":"crossref","DOI":"10.1016\/j.sbi.2023.102537","article-title":"Artificial intelligence in multi-objective drug design","volume":"79","author":"Luukkonen","year":"2023","journal-title":"Current Opinion in Structural Biology"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109092_bb0545","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/s41589-022-01234-w","article-title":"Modeling the expansion of virtual screening libraries","volume":"19","author":"Lyu","year":"2023","journal-title":"Nature Chemical Biology"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109092_bb0550","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/s41579-023-00993-0","article-title":"Alternative therapeutic strategies to treat antibiotic-resistant pathogens","volume":"22","author":"MacNair","year":"2024","journal-title":"Nature Reviews Microbiology"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.109092_bb0555","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.00486-24","article-title":"Insights into the molecular basis of reduced vancomycin susceptibility among three prominent Staphylococcus aureus clonal complexes","volume":"12","author":"Malachowa","year":"2024","journal-title":"Microbiology Spectrum"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.109092_bb0560","first-page":"1425","article-title":"AI designs de novo antibiotics","volume":"43","author":"Marchal","year":"2025","journal-title":"Nature Biotechnology"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109092_bb0565","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1146\/annurev-pharmtox-051921-023255","article-title":"Artificial intelligence and machine learning for lead-to-candidate decision-making and beyond","volume":"63","author":"McNair","year":"2023","journal-title":"Annual Review of Pharmacology and Toxicology"},{"issue":"11","key":"10.1016\/j.pharmthera.2026.109092_bb0570","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.3390\/antibiotics10111406","article-title":"Mechanisms of resistance to macrolide antibiotics among Staphylococcus aureus","volume":"10","author":"Miklasi\u0144ska-Majdanik","year":"2021","journal-title":"Antibiotics"},{"issue":"D1","key":"10.1016\/j.pharmthera.2026.109092_bb0575","doi-asserted-by":"crossref","first-page":"D412","DOI":"10.1093\/nar\/gkaa913","article-title":"Pfam: The protein families database in 2021","volume":"49","author":"Mistry","year":"2021","journal-title":"Nucleic Acids Research"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109092_bb0580","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2024.102122","article-title":"Promising strategies employing nucleic acids as antimicrobial drugs","volume":"35","author":"Moreira","year":"2024","journal-title":"Molecular Therapy--Nucleic Acids"},{"issue":"23","key":"10.1016\/j.pharmthera.2026.109092_bb0585","doi-asserted-by":"crossref","first-page":"14780","DOI":"10.1021\/acs.jmedchem.0c01265","article-title":"From pyrazolones to azaindoles: Evolution of active-site SHP2 inhibitors based on scaffold hopping and Bioisosteric replacement","volume":"63","author":"Mostinski","year":"2020","journal-title":"Journal of Medicinal Chemistry"},{"issue":"10325","key":"10.1016\/j.pharmthera.2026.109092_bb0590","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: A systematic analysis","volume":"399","author":"Murray","year":"2022","journal-title":"The Lancet"},{"issue":"7","key":"10.1016\/j.pharmthera.2026.109092_bb0595","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1021\/acs.accounts.1c00020","article-title":"Discovery of macrolide antibiotics effective against multi-drug resistant gram-negative pathogens","volume":"54","author":"Myers","year":"2021","journal-title":"Accounts of Chemical Research"},{"issue":"16","key":"10.1016\/j.pharmthera.2026.109092_bb0600","doi-asserted-by":"crossref","first-page":"6888","DOI":"10.1021\/acs.cgd.4c00422","article-title":"Importance of Structural Databases, Molecular Pharmacophores, Supramolecular Heterosynthons, and Artificial Intelligence\u2013Machine Learning\u2013Neural Network Tools in Drug Discovery","volume":"24","author":"Nangia","year":"2024","journal-title":"Crystal Growth & Design"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109092_bb0605","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1002\/med.70002","article-title":"How artificial intelligence assists in overcoming drug resistance?","volume":"45","author":"Ndikuryayo","year":"2025","journal-title":"Medicinal Research Reviews"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109092_bb0610","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1515\/hsz-2013-0292","article-title":"Tetracycline antibiotics and resistance mechanisms","volume":"395","author":"Nguyen","year":"2014","journal-title":"Biological Chemistry"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109092_bb0615","doi-asserted-by":"crossref","DOI":"10.48130\/targetome-0026-0019","article-title":"Degradation-based protein profiling in target identification and early-stage drug discovery of bioactive natural products","volume":"2","author":"Ni","year":"2026","journal-title":"Targetome"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109092_bb0620","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13321-025-00965-x","article-title":"DrugDiff-small molecule diffusion model with flexible guidance towards molecular properties","volume":"17","author":"Oestreich","year":"2025","journal-title":"Journal of Cheminformatics"},{"issue":"10442","key":"10.1016\/j.pharmthera.2026.109092_bb0625","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1016\/S0140-6736(24)00876-6","article-title":"The scope of the antimicrobial resistance challenge","volume":"403","author":"Okeke","year":"2024","journal-title":"The Lancet"},{"key":"10.1016\/j.pharmthera.2026.109092_bb0630","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2024.1437602","article-title":"Artificial intelligence tools for the identification of antibiotic resistance genes","volume":"15","author":"Olatunji","year":"2024","journal-title":"Frontiers in Microbiology"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109092_bb0635","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41592-021-01357-3","article-title":"Structural biology is solved\u2014Now what?","volume":"19","author":"Ourmazd","year":"2022","journal-title":"Nature Methods"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109092_bb0640","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3390\/ph19020301","article-title":"Rethinking nature\u2019s pharmacy: AI era and natural product drug discovery","volume":"19","author":"Paerhati","year":"2026","journal-title":"Pharmaceuticals"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109092_bb0645","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s43588-023-00399-1","article-title":"Large language model for molecular chemistry","volume":"3","author":"Pan","year":"2023","journal-title":"Nature Computational Science"},{"issue":"12","key":"10.1016\/j.pharmthera.2026.109092_bb0650","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01288-17","article-title":"Modified penicillin molecule with Carbapenem-like stereochemistry specifically inhibits class C \u03b2-lactamases","volume":"61","author":"Pan","year":"2017","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.pharmthera.2026.109092_bb0655","doi-asserted-by":"crossref","DOI":"10.1016\/j.coche.2025.101217","article-title":"The elephant in the lab: Synthesizability in generative small-molecule design","volume":"51","author":"Papidocha","year":"2026","journal-title":"Current Opinion in Chemical Engineering"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109092_bb0660","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41579-025-01226-2","article-title":"Methicillin-resistant and susceptible Staphylococcus aureus: Tolerance, immune evasion and treatment","volume":"24","author":"Parsons","year":"2026","journal-title":"Nature Reviews Microbiology"},{"key":"10.1016\/j.pharmthera.2026.109092_bb0665","doi-asserted-by":"crossref","first-page":"53","DOI":"10.35652\/IGJPS.2022.12006","article-title":"A review on computational software tools for drug design and discovery","volume":"12","author":"Patel","year":"2022","journal-title":"Indo Global Journal of Pharmaceutical Sciences"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109092_bb0670","doi-asserted-by":"crossref","first-page":"890","DOI":"10.3390\/molecules24050890","article-title":"Machine learning analyses on data including essential oil chemical composition and in vitro experimental antibiofilm activities against Staphylococcus species","volume":"24","author":"Patsilinakos","year":"2019","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109092_bb0675","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1146\/annurev-biochem-060614-034516","article-title":"Mechanisms of methicillin resistance in Staphylococcus aureus","volume":"84","author":"Peacock","year":"2015","journal-title":"Annual Review of Biochemistry"},{"issue":"7","key":"10.1016\/j.pharmthera.2026.109092_bb0680","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2026.01.003","article-title":"Unified modeling of 3D molecular generation via atomic interactions with PocketXMol","volume":"189","author":"Peng","year":"2026","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109092_bb0685","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41564-019-0634-z","article-title":"Safety of bacteriophage therapy in severe Staphylococcus aureus infection","volume":"5","author":"Petrovic Fabijan","year":"2020","journal-title":"Nature Microbiology"},{"issue":"18","key":"10.1016\/j.pharmthera.2026.109092_bb0690","doi-asserted-by":"crossref","first-page":"8207","DOI":"10.1021\/acs.jmedchem.6b00448","article-title":"\u0392-Lactamases: Why and how","volume":"59","author":"Pratt","year":"2016","journal-title":"Journal of Medicinal Chemistry"},{"issue":"7706","key":"10.1016\/j.pharmthera.2026.109092_bb0695","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s41586-018-0124-0","article-title":"Mutant phenotypes for thousands of bacterial genes of unknown function","volume":"557","author":"Price","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2026.109092_bb0700","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.914017","article-title":"Identification of therapeutic targets for amyotrophic lateral sclerosis using PandaOmics\u2013an AI-enabled biological target discovery platform","volume":"14","author":"Pun","year":"2022","journal-title":"Frontiers in Aging Neuroscience"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.109092_bb0705","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.tips.2023.06.010","article-title":"AI-powered therapeutic target discovery","volume":"44","author":"Pun","year":"2023","journal-title":"Trends in Pharmacological Sciences"},{"key":"10.1016\/j.pharmthera.2026.109092_bb0710","doi-asserted-by":"crossref","DOI":"10.1038\/s41573-026-01412-8","article-title":"Target identification and assessment in the era of AI","author":"Pun","year":"2026","journal-title":"Nature Reviews Drug Discovery"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109092_bb0715","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41413-023-00287-4","article-title":"Evidence of bisphosphonate-conjugated sitafloxacin eradication of established methicillin-resistant S. Aureus infection with osseointegration in murine models of implant-associated osteomyelitis","volume":"11","author":"Ren","year":"2023","journal-title":"Bone Research"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109092_bb0720","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s13054-023-04466-x","article-title":"Impact of macrolide treatment on long-term mortality in patients admitted to the ICU due to CAP: A targeted maximum likelihood estimation and survival analysis","volume":"27","author":"Reyes","year":"2023","journal-title":"Critical Care"},{"issue":"10","key":"10.1016\/j.pharmthera.2026.109092_bb0725","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.3390\/ph18101536","article-title":"From AI-assisted in silico computational design to preclinical in vivo models: A multi-platform approach to small molecule anti-IBD drug discovery","volume":"18","author":"Ripa","year":"2025","journal-title":"Pharmaceuticals"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109092_bb0730","doi-asserted-by":"crossref","DOI":"10.1128\/aac.01402-24","article-title":"Ceftobiprole activity against multidrug-resistant Staphylococcus aureus clinical isolates collected in the United States from 2016 through 2022","volume":"69","author":"Sader","year":"2025","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.109092_bb0735","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S1473-3099(25)00118-5","article-title":"The WHO bacterial priority pathogens list 2024: A prioritisation study to guide research, development, and public health strategies against antimicrobial resistance","volume":"25","author":"Sati","year":"2025","journal-title":"The Lancet Infectious Diseases"},{"key":"10.1016\/j.pharmthera.2026.109092_bb0740","article-title":"Deep-learning-based virtual screening of antibacterial compounds","author":"Scalia","year":"2025","journal-title":"Nature Biotechnology"},{"issue":"Suppl. 1","key":"10.1016\/j.pharmthera.2026.109092_bb0745","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1469-0691.2006.01343.x","article-title":"The importance of the development of antibiotic resistance in Staphylococcus aureus","volume":"12","author":"Schito","year":"2006","journal-title":"Clinical Microbiology and Infection"},{"issue":"12","key":"10.1016\/j.pharmthera.2026.109092_bb0750","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/s43588-024-00737-x","article-title":"Structure-based drug design with equivariant diffusion models","volume":"4","author":"Schneuing","year":"2024","journal-title":"Nature Computational Science"},{"issue":"12","key":"10.1016\/j.pharmthera.2026.109092_bb0755","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1007\/s40265-020-01358-0","article-title":"Delafloxacin: A review in acute bacterial skin and skin structure infections","volume":"80","author":"Scott","year":"2020","journal-title":"Drugs"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109092_bb0760","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1021\/acs.jcim.3c01562","article-title":"AutoMolDesigner for antibiotic discovery: An AI-based open-source software for automated design of small-molecule antibiotics","volume":"64","author":"Shen","year":"2024","journal-title":"Journal of Chemical Information and Modeling"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109092_bb0765","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s40265-025-02258-x","article-title":"Aztreonam-avibactam: A review in the treatment of serious bacterial infections caused by aerobic gram-negative organisms: M. Shirley","volume":"86","author":"Shirley","year":"2026","journal-title":"Drugs"},{"issue":"D1","key":"10.1016\/j.pharmthera.2026.109092_bb0770","doi-asserted-by":"crossref","first-page":"D715","DOI":"10.1093\/nar\/gkaf1254","article-title":"BV-BRC: A unified bacterial and viral bioinformatics resource with expanded functionality and AI integration","volume":"54","author":"Shukla","year":"2026","journal-title":"Nucleic Acids Research"},{"key":"10.1016\/j.pharmthera.2026.109092_bb0775","doi-asserted-by":"crossref","DOI":"10.1016\/j.sbi.2025.103020","article-title":"Recent advances in AI-driven protein-ligand interaction predictions","volume":"92","author":"Sim","year":"2025","journal-title":"Current Opinion in Structural Biology"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109092_bb0780","doi-asserted-by":"crossref","DOI":"10.1038\/s41698-025-01111-4","article-title":"DeepTarget predicts anti-cancer mechanisms of action of small molecules by integrating drug and genetic screens","volume":"9","author":"Sinha","year":"2025","journal-title":"npj Precision Oncology"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.109092_bb0785","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1128\/AEM.00036-15","article-title":"Methicillin-resistant Staphylococcus aureus in commercial swine herds is associated with disinfectant and zinc usage","volume":"81","author":"Slifierz","year":"2015","journal-title":"Applied and Environmental Microbiology"},{"key":"10.1016\/j.pharmthera.2026.109092_bb0790","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.bcp.2016.12.001","article-title":"Lincosamides: Chemical structure, biosynthesis, mechanism of action, resistance, and applications","volume":"133","author":"Sp\u00ed\u017eek","year":"2017","journal-title":"Biochemical Pharmacology"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109092_bb0795","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.cell.2020.04.001","article-title":"A deep learning approach to antibiotic discovery","volume":"181","author":"Stokes","year":"2020","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109092_bb0800","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1146\/annurev-pharmtox-062624-014243","article-title":"A mechanistic framework for repurposing FDA-approved drugs to combat antimicrobial resistance: The case of Staphylococcus aureus","volume":"66","author":"Sun","year":"2026","journal-title":"Annual Review of Pharmacology and Toxicology"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109092_bb0805","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/s42256-024-00809-7","article-title":"Generative AI for designing and validating easily synthesizable and structurally novel antibiotics","volume":"6","author":"Swanson","year":"2024","journal-title":"Nature Machine Intelligence"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109092_bb0810","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2025.104589","article-title":"From obstacle to design advantage: Activity cliff aware modeling for small-molecule drug discovery","volume":"31","author":"Szostek","year":"2026","journal-title":"Drug Discovery Today"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109092_bb0815","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","article-title":"Discovery, research, and development of new antibiotics: The WHO priority list of antibiotic-resistant bacteria and tuberculosis","volume":"18","author":"Tacconelli","year":"2018","journal-title":"Lancet Infectious Diseases"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109092_bb0820","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2023.103491","article-title":"Artificial intelligence as a smart approach to develop antimicrobial drug molecules: A paradigm to combat drug-resistant infections","volume":"28","author":"Talat","year":"2023","journal-title":"Drug Discovery Today"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109092_bb0825","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1186\/s12859-022-05053-7","article-title":"GSAMDA: A computational model for predicting potential microbe\u2013drug associations based on graph attention network and sparse autoencoder","volume":"23","author":"Tan","year":"2022","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.pharmthera.2026.109092_bb0830","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.118266","article-title":"4-Hydroxy-2,5-dihydrothiazole derivatives as a new class of small-molecule antibiotics for MRSA: AI-integrated design, chemical synthesis and biological evaluation","volume":"302","author":"Teng","year":"2026","journal-title":"European Journal of Medicinal Chemistry"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109092_bb0835","doi-asserted-by":"crossref","first-page":"370","DOI":"10.3390\/antibiotics10040370","article-title":"Recent trends in synthesis of chloramphenicol new derivatives","volume":"10","author":"Tevyashova","year":"2021","journal-title":"Antibiotics"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.109092_bb0840","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/s41579-025-01167-w","article-title":"Global health perspectives on antibacterial drug discovery and the preclinical pipeline","volume":"23","author":"Theuretzbacher","year":"2025","journal-title":"Nature Reviews Microbiology"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109092_bb0845","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/s41576-025-00907-1","article-title":"Harnessing artificial intelligence to advance CRISPR-based genome editing technologies","volume":"27","author":"Thomson","year":"2026","journal-title":"Nature Reviews Genetics"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.109092_bb0850","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00460-25","article-title":"NorA and Tet38 efflux pumps enable Staphylococcus aureus survival in the cystic fibrosis airway environment, resistance to antibiotics, and coinfection with Pseudomonas aeruginosa","volume":"69","author":"Truong-Bolduc","year":"2025","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109092_bb0855","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3390\/antibiotics10040394","article-title":"New chloramphenicol derivatives with a modified Dichloroacetyl tail as potential antimicrobial agents","volume":"10","author":"Tsirogianni","year":"2021","journal-title":"Antibiotics"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109092_bb0860","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41579-018-0147-4","article-title":"Methicillin-resistant Staphylococcus aureus: An overview of basic and clinical research","volume":"17","author":"Turner","year":"2019","journal-title":"Nature Reviews Microbiology"},{"issue":"D1","key":"10.1016\/j.pharmthera.2026.109092_bb0865","doi-asserted-by":"crossref","first-page":"D439","DOI":"10.1093\/nar\/gkab1061","article-title":"AlphaFold protein structure database: Massively expanding the structural coverage of protein-sequence space with high-accuracy models","volume":"50","author":"Varadi","year":"2022","journal-title":"Nucleic Acids Research"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109092_bb0870","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.02642-25","article-title":"Unraveling the mouse model of <i>Staphylococcus aureus<\/i> bacteremia and sepsis: A systematic approach to better characterize host\/pathogen interactions","volume":"14","author":"Vastola","year":"2026","journal-title":"Microbiology Spectrum"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109092_bb0875","article-title":"Multi-target mode of action of silver against Staphylococcus aureus endows it with capability to combat antibiotic resistance","volume":"12","author":"Wang","year":"2021","journal-title":"Nature Communications"},{"issue":"11","key":"10.1016\/j.pharmthera.2026.109092_bb0880","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1021\/ci500253q","article-title":"Discovering new agents active against methicillin-resistant Staphylococcus aureus with ligand-based approaches","volume":"54","author":"Wang","year":"2014","journal-title":"Journal of Chemical Information and Modeling"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109092_bb0885","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/s41396-023-01393-1","article-title":"Cooperative antibiotic resistance facilitates horizontal gene transfer","volume":"17","author":"Wang","year":"2023","journal-title":"The ISME Journal"},{"issue":"W1","key":"10.1016\/j.pharmthera.2026.109092_bb0890","doi-asserted-by":"crossref","first-page":"W356","DOI":"10.1093\/nar\/gkx374","article-title":"PharmMapper 2017 update: A web server for potential drug target identification with a comprehensive target pharmacophore database","volume":"45","author":"Wang","year":"2017","journal-title":"Nucleic Acids Research"},{"key":"10.1016\/j.pharmthera.2026.109092_bb0895","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112931","article-title":"Polypharmacological drug actions of recently FDA approved antibiotics","volume":"209","author":"Wetzel","year":"2021","journal-title":"European Journal of Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2026.109092_bb0900","article-title":"One in six bacterial infections worldwide are now resistant to antibiotics, WHO warns","volume":"391","author":"Wise","year":"2025","journal-title":"BMJ"},{"issue":"7997","key":"10.1016\/j.pharmthera.2026.109092_bb0905","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/s41586-023-06887-8","article-title":"Discovery of a structural class of antibiotics with explainable deep learning","volume":"626","author":"Wong","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2026.109092_bb0910","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116697","article-title":"Multi-target anti-MRSA mechanism and antibiotic synergistic effect of marine alkaloid Ascomylactam a in vitro and in vivo against clinical MRSA strains","volume":"232","author":"Wu","year":"2025","journal-title":"Biochemical Pharmacology"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109092_bb0915","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2025.107690","article-title":"Machine\u2013learning and gene\u2013synergy networks reveal interpretable drivers of antibiotic resistance in Staphylococcus aureus","volume":"67","author":"Xu","year":"2026","journal-title":"International Journal of Antimicrobial Agents"},{"key":"10.1016\/j.pharmthera.2026.109092_bb0920","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.667415","article-title":"A conjugative MDR pMG1-like plasmid carrying the lsa(E) gene of Enterococcus faecium with potential transmission to Staphylococcus aureus","volume":"12","author":"Yan","year":"2021","journal-title":"Frontiers in Microbiology"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109092_bb0925","doi-asserted-by":"crossref","DOI":"10.1128\/cmr.00161-23","article-title":"Recent development and fighting strategies for lincosamide antibiotic resistance","volume":"37","author":"Yang","year":"2024","journal-title":"Clinical Microbiology Reviews"},{"key":"10.1016\/j.pharmthera.2026.109092_bb0930","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3389\/fchem.2020.00142","article-title":"LigBuilder V3: a multi-target de novo drug design approach","volume":"8","author":"Yuan","year":"2020","journal-title":"Frontiers in Chemistry"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109092_bb0935","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s40265-022-01688-1","article-title":"Sulopenem: An intravenous and oral penem for the treatment of urinary tract infections due to multidrug-resistant bacteria","volume":"82","author":"Zhanel","year":"2022","journal-title":"Drugs"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109092_bb0940","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/cns.13092","article-title":"Macrolide derivatives reduce proinflammatory macrophage activation and macrophage-mediated neurotoxicity","volume":"25","author":"Zhang","year":"2019","journal-title":"CNS Neuroscience & Therapeutics"},{"key":"10.1016\/j.pharmthera.2026.109092_bb0945","article-title":"Deep learning speeds the search for new antibiotic scaffolds","author":"Zhang","year":"2025","journal-title":"Nature Biotechnology"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109092_bb0950","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1145\/3769677","article-title":"Structure-based drug design with geometric deep learning: A comprehensive survey","volume":"58","author":"Zhang","year":"2025","journal-title":"ACM Computing Surveys"},{"key":"10.1016\/j.pharmthera.2026.109092_bb0955","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.jare.2025.08.001","article-title":"Emerging host-directed strategies for overcoming drug resistance and immune evasion in Staphylococcus aureus infections","volume":"83","author":"Zheng","year":"2026","journal-title":"Journal of Advanced Research"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109092_bb0960","doi-asserted-by":"crossref","first-page":"7761","DOI":"10.1038\/s41467-024-52061-7","article-title":"An artificial intelligence accelerated virtual screening platform for drug discovery","volume":"15","author":"Zhou","year":"2024","journal-title":"Nature Communications"},{"issue":"23","key":"10.1016\/j.pharmthera.2026.109092_bb0965","doi-asserted-by":"crossref","first-page":"8415","DOI":"10.3390\/jcm14238415","article-title":"The therapeutic potential of Cefiderocol in the treatment of multidrug-resistant gram-negative Bacteria: A narrative review","volume":"14","author":"Z\u0142otowska","year":"2025","journal-title":"Journal of Clinical Medicine"}],"container-title":["Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725826001191?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725826001191?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:17:25Z","timestamp":1786119445000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725826001191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":193,"alternative-id":["S0163725826001191"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2026.109092","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AI-assisted design of next-generation antibiotics against multidrug-resistant Staphylococcus aureus","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2026.109092","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109092"}}